Influenza (Flu) Antiviral Drugs
Influenza (Flu) Antiviral Drugs market is segmented by region (country), players, by Type and by ... Read More
Global and United States Innovative Drug Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Innovative Drug Revenue in Innovative Drug Business (2017-2022) & (US$ Million) Introduction
1.2 Global Innovative Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Innovative Drug Market Size for the Year 2017-2028
1.2.2 Global Innovative Drug Market Size for the Year 2017-2028
1.3 Innovative Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Innovative Drug in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Innovative Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Innovative Drug Market Dynamics
1.4.1 Innovative Drug Industry Trends
1.4.2 Innovative Drug Market Drivers
1.4.3 Innovative Drug Market Challenges
1.4.4 Innovative Drug Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Innovative Drug by Type
2.1 Innovative Drug Market Segment by Type
2.1.1 Biological Medicine
2.1.2 Chemical Medicine
2.2 Global Innovative Drug Market Size by Type (2017, 2022 & 2028)
2.3 Global Innovative Drug Market Size by Type (2017-2028)
2.4 United States Innovative Drug Market Size by Type (2017, 2022 & 2028)
2.5 United States Innovative Drug Market Size by Type (2017-2028)
3 Innovative Drug by Application
3.1 Innovative Drug Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Pharmacy
3.1.3 Others
3.2 Global Innovative Drug Market Size by Application (2017, 2022 & 2028)
3.3 Global Innovative Drug Market Size by Application (2017-2028)
3.4 United States Innovative Drug Market Size by Application (2017, 2022 & 2028)
3.5 United States Innovative Drug Market Size by Application (2017-2028)
4 Global Innovative Drug Competitor Landscape by Company
4.1 Global Innovative Drug Market Size by Company
4.1.1 Top Global Innovative Drug Companies Ranked by Revenue (2021)
4.1.2 Global Innovative Drug Revenue by Player (2017-2022)
4.2 Global Innovative Drug Concentration Ratio (CR)
4.2.1 Innovative Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Innovative Drug in 2021
4.2.3 Global Innovative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Innovative Drug Headquarters, Revenue in Innovative Drug Business (2017-2022) & (US$ Million) Type
4.3.1 Global Innovative Drug Headquarters and Area Served
4.3.2 Global Innovative Drug Companies Revenue in Innovative Drug Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Innovative Drug Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Innovative Drug Market Size by Company
4.5.1 Top Innovative Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Innovative Drug Revenue by Players (2020, 2021 & 2022)
5 Global Innovative Drug Market Size by Region
5.1 Global Innovative Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Innovative Drug Market Size by Region (2017-2028)
5.2.1 Global Innovative Drug Market Size by Region: 2017-2022
5.2.2 Global Innovative Drug Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Innovative Drug Market Size YoY Growth 2017-2028
6.1.2 North America Innovative Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Innovative Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Innovative Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Innovative Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Innovative Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Innovative Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Innovative Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Innovative Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Innovative Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Details
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Innovative Drug Introduction
7.1.4 Pfizer Revenue in Innovative Drug Business (2017-2022)
7.1.5 Pfizer Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche Innovative Drug Introduction
7.2.4 Roche Revenue in Innovative Drug Business (2017-2022)
7.2.5 Roche Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Details
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Innovative Drug Introduction
7.3.4 Sanofi Revenue in Innovative Drug Business (2017-2022)
7.3.5 Sanofi Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Details
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Innovative Drug Introduction
7.4.4 Johnson & Johnson Revenue in Innovative Drug Business (2017-2022)
7.4.5 Johnson & Johnson Recent Development
7.5 Merck & Co. (MSD)
7.5.1 Merck & Co. (MSD) Company Details
7.5.2 Merck & Co. (MSD) Business Overview
7.5.3 Merck & Co. (MSD) Innovative Drug Introduction
7.5.4 Merck & Co. (MSD) Revenue in Innovative Drug Business (2017-2022)
7.5.5 Merck & Co. (MSD) Recent Development
7.6 Novartis
7.6.1 Novartis Company Details
7.6.2 Novartis Business Overview
7.6.3 Novartis Innovative Drug Introduction
7.6.4 Novartis Revenue in Innovative Drug Business (2017-2022)
7.6.5 Novartis Recent Development
7.7 AbbVie
7.7.1 AbbVie Company Details
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Innovative Drug Introduction
7.7.4 AbbVie Revenue in Innovative Drug Business (2017-2022)
7.7.5 AbbVie Recent Development
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Details
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Innovative Drug Introduction
7.8.4 Gilead Sciences Revenue in Innovative Drug Business (2017-2022)
7.8.5 Gilead Sciences Recent Development
7.9 GlaxoSmithKline (GSK)
7.9.1 GlaxoSmithKline (GSK) Company Details
7.9.2 GlaxoSmithKline (GSK) Business Overview
7.9.3 GlaxoSmithKline (GSK) Innovative Drug Introduction
7.9.4 GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2017-2022)
7.9.5 GlaxoSmithKline (GSK) Recent Development
7.10 Amgen
7.10.1 Amgen Company Details
7.10.2 Amgen Business Overview
7.10.3 Amgen Innovative Drug Introduction
7.10.4 Amgen Revenue in Innovative Drug Business (2017-2022)
7.10.5 Amgen Recent Development
7.11 AstraZeneca
7.11.1 AstraZeneca Company Details
7.11.2 AstraZeneca Business Overview
7.11.3 AstraZeneca Innovative Drug Introduction
7.11.4 AstraZeneca Revenue in Innovative Drug Business (2017-2022)
7.11.5 AstraZeneca Recent Development
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Company Details
7.12.2 Bristol-Myers Squibb Business Overview
7.12.3 Bristol-Myers Squibb Innovative Drug Introduction
7.12.4 Bristol-Myers Squibb Revenue in Innovative Drug Business (2017-2022)
7.12.5 Bristol-Myers Squibb Recent Development
7.13 Eli Lilly
7.13.1 Eli Lilly Company Details
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Innovative Drug Introduction
7.13.4 Eli Lilly Revenue in Innovative Drug Business (2017-2022)
7.13.5 Eli Lilly Recent Development
7.14 Teva
7.14.1 Teva Company Details
7.14.2 Teva Business Overview
7.14.3 Teva Innovative Drug Introduction
7.14.4 Teva Revenue in Innovative Drug Business (2017-2022)
7.14.5 Teva Recent Development
7.15 Bayer
7.15.1 Bayer Company Details
7.15.2 Bayer Business Overview
7.15.3 Bayer Innovative Drug Introduction
7.15.4 Bayer Revenue in Innovative Drug Business (2017-2022)
7.15.5 Bayer Recent Development
7.16 Novo Nordisk
7.16.1 Novo Nordisk Company Details
7.16.2 Novo Nordisk Business Overview
7.16.3 Novo Nordisk Innovative Drug Introduction
7.16.4 Novo Nordisk Revenue in Innovative Drug Business (2017-2022)
7.16.5 Novo Nordisk Recent Development
7.17 Allergan
7.17.1 Allergan Company Details
7.17.2 Allergan Business Overview
7.17.3 Allergan Innovative Drug Introduction
7.17.4 Allergan Revenue in Innovative Drug Business (2017-2022)
7.17.5 Allergan Recent Development
7.18 Takeda
7.18.1 Takeda Company Details
7.18.2 Takeda Business Overview
7.18.3 Takeda Innovative Drug Introduction
7.18.4 Takeda Revenue in Innovative Drug Business (2017-2022)
7.18.5 Takeda Recent Development
7.19 Boehringer Ingelheim
7.19.1 Boehringer Ingelheim Company Details
7.19.2 Boehringer Ingelheim Business Overview
7.19.3 Boehringer Ingelheim Innovative Drug Introduction
7.19.4 Boehringer Ingelheim Revenue in Innovative Drug Business (2017-2022)
7.19.5 Boehringer Ingelheim Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Innovative Drug Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Innovative Drug Market Trends
Table 3. Innovative Drug Market Drivers
Table 4. Innovative Drug Market Challenges
Table 5. Innovative Drug Market Restraints
Table 6. Global Innovative Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Innovative Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Innovative Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Innovative Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Innovative Drug Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Innovative Drug Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Innovative Drug Revenue Share by Player, 2017-2022
Table 13. Global Innovative Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Innovative Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug as of 2021)
Table 15. Top Players of Innovative Drug in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Innovative Drug Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Innovative Drug Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Innovative Drug Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Innovative Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Innovative Drug Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Innovative Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Innovative Drug Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Innovative Drug Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Innovative Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Innovative Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Innovative Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Innovative Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Innovative Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Pfizer Company Details
Table 31. Pfizer Business Overview
Table 32. Pfizer Innovative Drug Product
Table 33. Pfizer Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 34. Pfizer Recent Development
Table 35. Roche Company Details
Table 36. Roche Business Overview
Table 37. Roche Innovative Drug Product
Table 38. Roche Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 39. Roche Recent Development
Table 40. Sanofi Company Details
Table 41. Sanofi Business Overview
Table 42. Sanofi Innovative Drug Product
Table 43. Sanofi Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 44. Sanofi Recent Development
Table 45. Johnson & Johnson Company Details
Table 46. Johnson & Johnson Business Overview
Table 47. Johnson & Johnson Innovative Drug Product
Table 48. Johnson & Johnson Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 49. Johnson & Johnson Recent Development
Table 50. Merck & Co. (MSD) Company Details
Table 51. Merck & Co. (MSD) Business Overview
Table 52. Merck & Co. (MSD) Innovative Drug Product
Table 53. Merck & Co. (MSD) Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 54. Merck & Co. (MSD) Recent Development
Table 55. Novartis Company Details
Table 56. Novartis Business Overview
Table 57. Novartis Innovative Drug Product
Table 58. Novartis Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. AbbVie Company Details
Table 61. AbbVie Business Overview
Table 62. AbbVie Innovative Drug Product
Table 63. AbbVie Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 64. AbbVie Recent Development
Table 65. Gilead Sciences Company Details
Table 66. Gilead Sciences Business Overview
Table 67. Gilead Sciences Innovative Drug Product
Table 68. Gilead Sciences Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 69. Gilead Sciences Recent Development
Table 70. GlaxoSmithKline (GSK) Company Details
Table 71. GlaxoSmithKline (GSK) Business Overview
Table 72. GlaxoSmithKline (GSK) Innovative Drug Product
Table 73. GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 74. GlaxoSmithKline (GSK) Recent Development
Table 75. Amgen Company Details
Table 76. Amgen Business Overview
Table 77. Amgen Innovative Drug Product
Table 78. Amgen Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 79. Amgen Recent Development
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Innovative Drug Product
Table 83. AstraZeneca Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 84. AstraZeneca Recent Development
Table 85. Bristol-Myers Squibb Company Details
Table 86. Bristol-Myers Squibb Business Overview
Table 87. Bristol-Myers Squibb Innovative Drug Product
Table 88. Bristol-Myers Squibb Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 89. Bristol-Myers Squibb Recent Development
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Innovative Drug Product
Table 93. Eli Lilly Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 94. Eli Lilly Recent Development
Table 95. Teva Company Details
Table 96. Teva Business Overview
Table 97. Teva Innovative Drug Product
Table 98. Teva Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 99. Teva Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Innovative Drug Product
Table 103. Bayer Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. Novo Nordisk Company Details
Table 106. Novo Nordisk Business Overview
Table 107. Novo Nordisk Innovative Drug Product
Table 108. Novo Nordisk Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 109. Novo Nordisk Recent Development
Table 110. Allergan Company Details
Table 111. Allergan Business Overview
Table 112. Allergan Innovative Drug Product
Table 113. Allergan Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 114. Allergan Recent Development
Table 115. Takeda Company Details
Table 116. Takeda Business Overview
Table 117. Takeda Innovative Drug Product
Table 118. Takeda Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 119. Takeda Recent Development
Table 120. Boehringer Ingelheim Company Details
Table 121. Boehringer Ingelheim Business Overview
Table 122. Boehringer Ingelheim Innovative Drug Product
Table 123. Boehringer Ingelheim Revenue in Innovative Drug Business (2017-2022) & (US$ Million)
Table 124. Boehringer Ingelheim Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Innovative Drug Product Picture
Figure 2. Global Innovative Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Innovative Drug Market Size 2017-2028 (US$ Million)
Figure 4. United States Innovative Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Innovative Drug Market Size 2017-2028 (US$ Million)
Figure 6. United States Innovative Drug Market Share in Global 2017-2028
Figure 7. Innovative Drug Report Years Considered
Figure 8. Product Picture of Biological Medicine
Figure 9. Product Picture of Chemical Medicine
Figure 10. Global Innovative Drug Market Share by Type in 2022 & 2028
Figure 11. Global Innovative Drug Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global Innovative Drug Market Share by Type (2017-2028)
Figure 13. United States Innovative Drug Market Share by Type in 2022 & 2028
Figure 14. United States Innovative Drug Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States Innovative Drug Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals and Clinics
Figure 17. Product Picture of Pharmacy
Figure 18. Product Picture of Others
Figure 19. Global Innovative Drug Market Share by Application in 2022 & 2028
Figure 20. Global Innovative Drug Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global Innovative Drug Market Share by Application (2017-2028)
Figure 22. United States Innovative Drug Market Share by Application in 2022 & 2028
Figure 23. United States Innovative Drug Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States Innovative Drug Market Share by Application (2017-2028)
Figure 25. North America Innovative Drug Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe Innovative Drug Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Innovative Drug Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America Innovative Drug Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Innovative Drug Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. UAE Innovative Drug Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Pfizer Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 54. Roche Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 55. Sanofi Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 56. Johnson & Johnson Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 57. Merck & Co. (MSD) Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 58. Novartis Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 59. AbbVie Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 60. Gilead Sciences Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 61. GlaxoSmithKline (GSK) Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 62. Amgen Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 63. AstraZeneca Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 65. Eli Lilly Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 66. Teva Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 67. Bayer Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 68. Novo Nordisk Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 69. Allergan Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 70. Takeda Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 71. Boehringer Ingelheim Revenue Growth Rate in Innovative Drug Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Roche Sanofi Johnson & Johnson Merck & Co. (MSD) Novartis AbbVie Gilead Sciences GlaxoSmithKline (GSK) Amgen AstraZeneca Bristol-Myers Squibb Eli Lilly Teva Bayer Novo Nordisk Allergan Takeda Boehringer Ingelheim